Search results for "Perspectives"


 
Results 41 - 50 of about 503 for "Perspectives".
Sort by: Relevance | Newest | Oldest

ACP's Patient and Interprofessional Partnership Initiative offers new toolkits

The General Team Care Toolkit shares best practices and real-life examples of team-based clinical care models, while the Engaging Informal Caregivers Toolkit helps physicians partner with caregivers.
https://immattersacp.org/weekly/archives/2021/06/08/6.htm
8 Jun 2021

Latest on COVID-19 and bamlanivimab, vaccines, long-term effects

Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
https://immattersacp.org/weekly/archives/2021/01/26/1.htm
26 Jan 2021

ACP, Annals of Internal Medicine host fifth forum on COVID-19

“COVID-19 Forum V: Evaluation and Care of Patients with Persistent Symptoms Following Acute SARS-CoV-2 Infection” was held on June 9.
https://immattersacp.org/weekly/archives/2021/06/15/2.htm
15 Jun 2021

Gout flares may precede cardiovascular events

A retrospective study found that gout patients who experienced an acute myocardial infarction or stroke had significantly higher odds of a recent gout flare in the preceding four months than those who did not.
https://immattersacp.org/weekly/archives/2022/08/09/1.htm
9 Aug 2022

DEI or DIE?

The College has become a leader in the world of justice, equity, diversity, and inclusion. While it is tempting to feel a sense of accomplishment, there is a gnawing feeling that more needs to be done.
https://immattersacp.org/archives/2021/05/dei-or-die.htm
1 May 2021

The road to advocacy's ‘Final Four’

Although ACP achieved major changes to the evaluation and management (E/M) codes, implementation of these changes has not been perfect. There is ongoing work to be done.
https://immattersacp.org/archives/2023/03/the-road-to-advocacys-final-four.htm
1 Mar 2023

Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging

An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
https://immattersacp.org/weekly/archives/2021/07/20/1.htm
20 Jul 2021

ACP policies target inequity to improve health

We must be intentional in our efforts to address the needs of individuals experiencing health care disparities and inequities based on social drivers of health.
https://immattersacp.org/archives/2022/09/acp-policies-target-inequity-to-improve-health.htm
1 Sep 2022

Research on COVID-19 vaccines' duration, reactions, prioritization

Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021

Stopping opioid treatment linked to increased risk of death from overdose or suicide in veterans

The risk of death from overdose or suicide increased immediately after starting or stopping opioids and continued to rise the longer patients were treated with opioids.
https://immattersacp.org/weekly/archives/2020/03/17/2.htm
17 Mar 2020

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next